Navigate to
472 Results for GLP-1 Pipeline Update
-
Name Manufacturer Clinical use Dosage form Development status - FDA designations FDA decision aflibercept (Eylea HD) 8 mg Regeneron Macular edema from RVO (8 mg dose) Intravitreal sNDA – PR Oct-Dec...
-
Jessica Johnson, clinical consultant, shares how the Special Investigations Unit at Prime helps identify cases of fraud
PA Sub-Categories: GLP-1 Prime Article: Perspectives -
Real-world, integrated data follows-up on previous insights, analytics.
PA Sub-Categories: GLP-1 Prime Article: Press Releases -